Dr Brett Paterson obtained his PhD in chemistry from the University of Melbourne. He is a synthetic inorganic/organic chemist with extensive experience in the design, synthesis and evaluation of radiotracers/radiopharmaceuticals for therapy and imaging applications. His current research interests include synthesis; bioconjugation chemistry; radiochemistry; peptide synthesis; nanotechnology; diagnostic imaging and radiotherapy; and multidisciplinary translational research. Dr Paterson was awarded a Victoria Fellowship in 2011, which he used to conduct postdoctoral research and receive specialist training in radiochemistry, biology and molecular imaging at King’s College London and Boston Children’s Hospital/Harvard Medical School. He received a Victorian Postdoctoral Research Fellowship in 2013 and returned to King’s College London, where he was investigating targeted alpha therapy (TAT). Dr Paterson was a Discovery Early Career Researcher Award (DECRA) Fellow in the School of Chemistry, Monash University from 2017 to 2019.
